Study links JAK inhibitor anti-inflammatory drugs to greater viral spread risk
Researchers at the Norwegian University of Science and Technology report that JAK inhibitors, a class of anti-inflammatory medicines, may weaken the body's natural defenses. By dampening immune responses, these drugs can make people more susceptible to viral infections such as COVID-19 and influenza. The findings suggest the viruses may find it easier to multiply and move through the body in patients taking them. The researchers advise clinicians to exercise caution when prescribing these drugs during periods of viral outbreaks.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.



Discussion (0)
Log in to join the discussion and vote.
Log in